PHARMAC is seeking feedback on one final proposal for the supply and funding of meningococcal C conjugate vaccine. In summary, the proposal would result in:

• Neisvac-C remaining as the only listed meningococcal C conjugate vaccine on the National Immunisation Schedule.
• the delisting of Neisvac-C in the 10 injection pack presentation.
• a correction of the chemical name for Neisvac-C in the Pharmaceutical Schedule.

The consultation can be found here:

 https://www.pharmac.govt.nz/news/consultation-2017-05-23-nis-men-c/

Please send feedback to [email protected] by Monday 5 June 2017.